Neoantigen quality, not quantity.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 31434757.
- Also identified by DOI 10.1126/scitranslmed.aax7918.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Prioritizing expressed clonal neoantigens in genes required for cancer cell survival may reduce the likelihood of resistance to neoantigen therapies.
Medical subject headings
- Antigens, Neoplasm